KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Edwards Lifesciences (EW) Receivables - Other (2016 - 2026)

Edwards Lifesciences has reported Receivables - Other over the past 17 years, most recently at $252.5 million for Q4 2025.

  • For Q4 2025, Receivables - Other rose 113.44% year-over-year to $252.5 million; the TTM value through Dec 2025 reached $252.5 million, up 113.44%, while the annual FY2025 figure was $252.5 million, 113.44% up from the prior year.
  • Receivables - Other for Q4 2025 was $252.5 million at Edwards Lifesciences, up from $199.5 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $252.5 million in Q4 2025 and troughed at $42.8 million in Q2 2022.
  • A 5-year average of $89.4 million and a median of $62.4 million in 2023 define the central range for Receivables - Other.
  • Biggest five-year swings in Receivables - Other: tumbled 47.87% in 2021 and later surged 266.49% in 2025.
  • Year by year, Receivables - Other stood at $82.7 million in 2021, then crashed by 32.16% to $56.1 million in 2022, then increased by 0.89% to $56.6 million in 2023, then soared by 109.01% to $118.3 million in 2024, then surged by 113.44% to $252.5 million in 2025.
  • Business Quant data shows Receivables - Other for EW at $252.5 million in Q4 2025, $199.5 million in Q3 2025, and $205.6 million in Q2 2025.